Results of a Phase II Trial with Cystemustine in Advanced Malignant Melanoma. a Trial of the EORTC Clinical Screening Group

European Journal of Cancer

Volumn 32, Issue 1, 1996, Pages 181-182

  Urosevic, V ^a   Chollet, Ph ^a   Adenis, A ^b   Chauvergne, J ^c   Fargeot, P ^d   Roche, H ^e   Kerbrat, P ^f   Lentz, M A ^g   Fumoleau, P ^h   Chevallier, B ⁱ  

^a CENTRE JEAN PERRIN   (France)

^b CENTRE OSCAR LAMBRET   (France)

^c Fondation Bergoinie   (France)

^d CENTRE GEORGES FRANÇOIS LECLERC   (France)

^e INSTITUT CLAUDIUS REGAUD   (France)

^f CENTRE EUGÈNE MARQUIS   (France)

^g EORTC DATA CENTER   (Belgium)

^h CENTRE RENÉ GAUDUCHEAU   (France)

ⁱ CENTRE HENRI BECQUEREL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEMUSTINE;

ADULT; ADVANCED CANCER; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MALE; MELANOMA; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NITROSOUREA COMPOUNDS; SKIN NEOPLASMS;

EID: 0029962798     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00473-4     Document Type: Letter

References (7)

1. Laurent R, Zultak M. Les mélanomes malins cutanés. Encycl Méd Chir Dermatologie (Paris, France), 1988, 12, 760, A10-7.
2. Mastrangelo MJ, Baker AR, Katz HR. Cutaneous melanoma. In De Vita VT Jr, Hellmann S, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology. Philadelphia, JB Lippincott, 1985, 1371-1422.
3. Karakousis CP, Moore R, MS, Holyoke ED. Surgery in recurrent malignant melanoma. Cancer 1983, 52, 1342-1345.
4. Avril MF, Bonneterre J, Cupissol D, et al. Fotemustine plus dacarbazine for malignant melanoma. Eur J Cancer 1992, 28A, 1807-1811.
5. Tisserant A, Curé H, Souteyrand P, et al. Pilot phase II trial of a new nitrosourea: cystemustine in disseminated malignant melanoma (abstract). Proc 7th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, The Netherlands, 17-20 March 1992: Abst. 295.
6. Adenis A, Chauvergne J, Fargeot P, et al. Results of a phase II trial with cystemustine in advanced malignant melanoma. Proceedings of the XVIIth Congress of the European Society for Medical Oncology, Lyon, France, 7-10 November 1992: Abst. 182.
7. Chollet Ph, Adenis A, Chauvergne J, et al. Results of two phase II trials with cystemustine in advanced malignant melanoma. Proceedings of the 8th NIC-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, The Netherlands, 15-18 March 1994: Abst. 290.